Insulin Aspart Injection
Fiasp
Insulin Analog
NADAC/unit
$6.9327
No Shortage
Tier 1: 53.8%
PA Req: 27.7%
Insulin Aspart Injection replaces or supplements natural insulin to control blood sugar in diabetes.
vs. brand Fiasp: Generic saves up to 31% per unit
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.